Characterization of Platelet Receptors and Their Involvement in Immune Activation of These Cells. [PDF]
Tokarz-Deptuła B+4 more
europepmc +1 more source
Effect of GPVI-Fc in combination with standard antiplatelet drugs and of GPVI-Fc fused to CD39 on platelet thrombus formation [PDF]
Mojica Muñoz, Ann-Katrin
core
The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signalling in platelets. [PDF]
Eble, JA+5 more
core +1 more source
Dengue infection changes the expressions of CD154 and CD148 in human platelets. [PDF]
Vedpathak S+4 more
europepmc +1 more source
Reactive oxygen species: Orchestrating the delicate dance of platelet life and death. [PDF]
Liao R+12 more
europepmc +1 more source
Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial. [PDF]
Pottecher J+14 more
europepmc +1 more source
Is glycoprotein VI involved in contractual negotiations? [PDF]
Brysland SA, Hearn JI, Gardiner EE.
europepmc +1 more source
Targeting Rap1b signaling cascades with CDNF: Mitigating platelet activation, plasma oxylipins and reperfusion injury in stroke. [PDF]
Wu JS+9 more
europepmc +1 more source
Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention. [PDF]
Contursi A+4 more
europepmc +1 more source
Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A. [PDF]
Althaus K+17 more
europepmc +1 more source